Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000430990 | SCV000531220 | uncertain significance | not provided | 2016-08-22 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the ARHGEF9 gene. The M347L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The M347L variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Methionine are tolerated across species, and Leucine is observed at this position in other species. However, M374L was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Labcorp Genetics |
RCV000685616 | SCV000813101 | likely benign | Developmental and epileptic encephalopathy, 8 | 2024-01-25 | criteria provided, single submitter | clinical testing |